Skip to main content
Clinical Trials/CTRI/2024/07/070131
CTRI/2024/07/070131
Not yet recruiting
Phase 3

A single arm clinical study to evaluate the efficacy of kalyanaka guda in the management of irritable bowel syndrome with special reference to vatika grahani - nil

ational Institute of Ayurveda, Deemed to be University, Jaipur0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K582- Mixed irritable bowel syndrome
Sponsor
ational Institute of Ayurveda, Deemed to be University, Jaipur
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda, Deemed to be University, Jaipur

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients between the age group of 18 to 60 years.
  • 2\.Patients irrespective of sex and socio\- economic status.
  • 3\.Patients having signs and symptoms (abdominal pain and altered bowel habits) of
  • Irritable Bowel Syndrome and Vatika Grahani like parshvavankshanruk, chiraat dukham drav shushkam tanu..punah punah srujeta varchah..

Exclusion Criteria

  • 1\. Mixed infection with parasites like round worms, hook worms etc.
  • 2\. Patients with bleeding per rectum.
  • 3\. Patients with evidence of malignancy.
  • 4\. Patients having concomitant illness like hypertension, diabetes mellitus type II,
  • Amoebic dysentery, Ulcerative colitis, Malabsorption syndrome,
  • Inflammatory Bowel Diseases \& Intestinal tuberculosis, Lactase deficiency
  • 5\. Patients suffering from major systemic illness like cancer, crohn’s disease, renal
  • failure etc.
  • 6\. Patients who are taking corticosteroids, antidepressants, anticholinergic, or
  • any other drugs that may have an influence on the outcome of study.

Outcomes

Primary Outcomes

Not specified

Similar Trials